العودة إلى الصفحة الرئيسية
4.6/5
TrustPilot

أفضل العلاج بالخلايا التائية ذات مستقبل المستضد الخيمري في أنقرة - توب -1 طبيب

قارن بين أفضل أطباء العلاج بالخلايا التائية ذات مستقبل المستضد الخيمري والأسعار في تركيا. اعثر على أفضل تطابق لك هنا.

احصل على عروض من أفضل 3 أخصائيي العلاج بالخلايا التائية ذات مستقبل المستضد الخيمري في تركيا

سنختار لك أفضل الأطباء حسب احتياجاتك وميزانيتك.

تمت مراجعة المقالة طبيا من قبل فهد مولود

محرر طبي وعالم بيانات

أفضل الأطباء

1

تركيا

التقييمات

14000+

من مرضى حقيقيين

اختر الدولة ذات أفضل الأسعار لخدمات الأطباء

قارن أسعار العلاج بالخلايا التائية ذات مستقبل المستضد الخيمري عبر أفضل الدول

اضغط على دولة لعرض أفضل الأطباء والأسعار

Israel
Ukraine
Turkey
Poland
Mexico
Thailand
$72,000 - $112,800
$150,000 - $250,000
$150,000 - $225,000
$150,000 - $250,000
$250,000 - $400,000
$250,000 - $350,000
$0
$64,000
$128,000
$192,000
$256,000
$320,000
$384,000

احصل على خطط علاجية مخصصة مجانية واختر أفضل خيار. بدون التزام · بدون دفعات لخدماتنا

Osman Ilhan

  • 48سنة خبره ١٦ سنة
  • اعتماد، موافقة رسمية:
  • الموقع: تركيا, أنقرة
  • كان البروفيسور الدكتور عثمان إلهان جزءًا من الفريق الذي أجرى أول عملية زرع خلايا جذعية لنخاع العظم في تركيا. وهو يقود الآن العلاج بالخلايا التائية CAR T في مستشفى كورو أنقرة الخاص.

    • أكثر من 50 عامًا من الخبرة في أمراض الدم وبحوث الخلايا الجذعية
    • تدرب في مركز MD Anderson للسرطان على زراعة الخلايا الجذعية
    • الرئيس المؤسس لجمعية العلاج الخلوي والطب التجديدي في تركيا
    • نشر أكثر من 300 ورقة بحثية مع أكثر من 5000 اقتباس في أمراض الدم
    • يحمل براءات اختراع لعلاجات أمراض الدم المبتكرة
  • اقرأ المزيد
تكلفة استشارة الطبيب
السعر عند الطلب

قد يكون اختيار العيادة في الخارج أمرًا مرهقًا. في Bookimed، حيث ساعدنا أكثر من 800 ألف مريض، نحن نتفهم مخاوفك. نعرف كيفية العثور على الأطباء الموثوقين، وأفضل خيارات الجودة والسعر، وحلول حتى للحالات المعقدة. نحن هنا لإرشادك في كل خطوة على الطريق.

Yan Matsiivskiy

رئيس فريق المنسق الطبي

تم توجيه أكثر من 4300+ رحلة مرضى

3 سنة في Bookimed

278 مريض من Turkey وجدوا طبيبهم عبرنا هذا الشهر

كيف ستحصل على مطابقة الطبيب المثالي لك

1

اختبار لمدة دقيقتين

أخبرنا بهدفك، ميزانيتك، وخطتك الزمنية

2

مطابقة بشرية + ذكاء اصطناعي

يجد خوارزمينا التطابقات، ويؤكد المنسق مدى الملاءمة

3

خياراتك جاهزة

قارن الأسعار، الباقات، والتواريخ. تحدث مع منسقك

تشعر بالحيرة لكثرة الخيارات؟

الشخصي الخاص بك يساعدك منسق Bookimed في إيجاد الجراح المثالي الملائم لاحتياجاتك

  • يدعمك 24/7 في كل مرحلة
  • يساعدك في مطابقة الطبيب ويتولى جميع الاتصالات مع العيادات
  • ينسق سفرك، إقامتك، وعمليات النقل

يوجه علاجك

منسقون شخصيون مدربون طبياً

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

اختيار الطبيب الأيمن والعيادة الطبية: نصائح الإدراك

عند تحديد الطبيب أو العيادة الطبية، ضع هذه النقاط الرئيسية في الاعتبار:
التحقق من أوراق الاعتماد
التحقق من الشهادات من هيئات مثل ISAPS، JCI، إلخ.
استعراض معدلات النجاح
اختر أطباء لديهم خبرة قوية وسجل مثبت في علاجك المحدد.
آراء المرضى
مراجعات Bookimed من مرضى حقيقيين لتصفح تجربتهم.
ضمان التواصل الفعال
اختيار العيادات التي تقدم الدعم اللغوي للعلاج السلس.
اسأل عن الخدمات
تأكد من أن السعر يشمل الخدمات مثل الإقامة، والتنقلات المحلية، والرعاية بعد العلاج لتفادي التكاليف الخفية.

رؤى Bookimed: أفضل أخصائيي العلاج بالخلايا التائية ذات مستقبل المستضد الخيمري في تركيا (2026)

نسقّت Bookimed 29 طلبًا لإجراء العلاج بالخلايا التائية ذات مستقبل المستضد الخيمري في تركيا، بالتعاون مع 1 من أفضل الأخصائيين. تم اختيار الأطباء في هذا الجدول بناءً على مؤهلاتهم الدولية، وخبراتهم السريرية، ونتائج المرضى. تم تشكيل التصنيف لعام 2026 باستخدام بيانات موثقة من حالات مرضى حقيقية وبرامج حالية من عياداتنا الشريكة.
الترتيب.طبيبخبرةمناسب لـما الذي يميزهم عن غيرهمالعيادة والموقعالاستشارة
#148سنة خبره ١٦ سنةالعلاج بالخلايا التائية CAR Tرائد في زراعة الخلايا الجذعية – أجرى أول عملية زرع نخاع عظم في تركيا. الرئيس المؤسس لجمعية العلاج الخلوي مع تدريب في MD Anderson.
تركيا
السعر عند الطلب

FAQ

هذه الأسئلة الشائعة مأخوذة من مرضى حقيقيين يبحثون عن رعاية طبية عبر Bookimed. يتم تقديم الإجابات من قبل منسقين طبيين ذوي خبرة وممثلين موثوقين من العيادات.

How do doctors in Turkey handle the logistics of CAR T-cell therapy?

Doctors in Turkey manage CAR T-cell therapy through a synchronized pipeline involving cell collection, specialized transport, and inpatient monitoring. Leading hematologists integrate international logistics with Joint Commission International (JCI) accredited facilities. They use the vein-to-vein model to maintain cell viability during engineering and re-infusion processes.

  • Cell collection: Specialists perform apheresis to harvest T-cells using temperature-controlled cryopreservation techniques.
  • Manufacturing logistics: Teams coordinate with domestic labs or international hubs to engineer patient cells.
  • Bridging therapy: Hematologists design temporary treatment regimens to stabilize the patient during the manufacturing period.
  • Post-infusion care: Patients stay in isolated bone marrow units for 14+ days to monitor progress.

Bookimed Expert Insight: Turkish specialists provide a significant clinical advantage through their extensive training at top global institutions. Dr. Osman Ilhan at Private Koru Ankara Hospital trained at MD Anderson Cancer Center. Dr. Ceyhun Bozkurt of Medical Park studied at Harvard and Cincinnati Children's. This international background allows them to manage complex cross-border cell manufacturing protocols efficiently.

Patient Consensus: Patients describe the process as a multi-step puzzle that requires staying near the hospital for several weeks. They note it is helpful to have the medical team handle shipping and customs paperwork. Many emphasize that clear communication about lab timelines and bed availability helps reduce stress during the wait.

Which medical specialties do CAR T-cell therapy doctors in Turkey hold?

CAR T-cell therapy doctors in Turkey primarily hold dual specializations in hematology and medical oncology. These experts focus on treating complex blood cancers through advanced cellular modification and bone marrow transplantation. Many specialists are internationally trained in molecular hematology and stem cell research.

  • Adult hematology: Physicians like Dr. Serdar Bedii Omay specialize in molecular blood disorders and transplantation.
  • Pediatric hematology-oncology: Experts like Dr. Ceyhun Bozkurt treat childhood leukemias using specialized cellular protocols.
  • Medical oncology: Specialists manage solid tumors and lymphomas while overseen by bone marrow transplant directors.
  • Stem cell transplantation: Doctors often lead JCI-accredited units with training from institutions like MD Anderson.

Bookimed Expert Insight: Leading Turkish specialists often hold academic leadership roles and possess extensive research backgrounds. For example, Dr. Osman Ilhan helped perform the first bone marrow transplant in Turkey. This indicates that patients receive care from pioneers who founded the country's cellular therapy associations and hold patents in hematology innovation.

Patient Consensus: Patients note that their care is guided by hematologist-oncologists while specialized transplant teams handle cell collection and infusion. Many highlight the importance of choosing centers with 24/7 inpatient monitoring to manage potential inflammatory reactions safely.

Do Turkish CAR T-cell doctors have international training or certifications?

Leading Turkish CAR T-cell therapy doctors maintain extensive international training and holds credentials from elite global medical institutions. These senior hematologists frequently complete fellowships and research tenures at centers like MD Anderson Cancer Center and Harvard University's Dana-Farber Cancer Institute.

  • Global training: Specialists like Dr. Osman Ilhan trained at MD Anderson and University of Genoa.
  • Elite affiliations: Many doctors hold active memberships in the European Society for Blood and Marrow Transplantation.
  • Academic leadership: Dr. Ceyhun Bozkurt conducted specialized research at Cincinnati Children's Hospital in the USA.
  • International research: Prof. Serdar Bedii Omay trained at Japan Mie Medical School and published 65+ articles.

Bookimed Expert Insight: Data shows that top Turkish hematologists often hold leadership roles in global regulatory bodies. For example, Dr. Osman Ilhan served as President of the Turkish Hematology Association and received a Platinum CME certificate from the European Hematology Association. This indicates that Turkish specialists are not just followers of global protocols but active contributors to international cellular therapy standards.

Patient Consensus: Patients note that while international degrees are impressive, the team's ability to manage treatment side effects is what truly matters. They emphasize checking if the hospital has a dedicated ICU and pharmacy support for complex cell therapies. Many feel more confident when the medical team has managed numerous cases and follows recognized CAR T pathways.

Who are the leading doctors offering adult CAR T-cell therapy in Turkey?

Leading specialists in Turkey for adult CAR T-cell therapy hold extensive backgrounds in hematology and stem cell transplantation. These experts typically practice at JCI-accredited facilities in Istanbul and Ankara. They possess specialized training from top international institutions and lead dedicated cellular immunotherapy programs for blood cancers.

  • Dr. Osman Ilhan: Pioneer who performed Turkey's first stem cell transplant with MD Anderson training.
  • Dr. Serdar Bedii Omay: Specialist in molecular hematology with doctoral training from Mie Medical School in Japan.
  • Dr. Bulent Eser: Member of the European Group for Blood and Marrow Transplantation at Medical Park.
  • Dr. Sarah Sirinoglu Temiz: Expert in therapeutic apheresis who previously managed specialized stem cell transplantation units.

Bookimed Expert Insight: Data shows that top hematologists in Turkey often hold cross-continental credentials. Dr. Serdar Bedii Omay and Dr. Osman Ilhan possess specific training from Japan, Italy, and the USA. This international exposure is vital for CAR T-cell therapy. It ensures they stay updated on global protocols for managing complex side effects like cytokine release syndrome.

Patient Consensus: Patients emphasize selecting centers that manage the entire cellular manufacturing process on-site. Realizing that the team has experience with specific post-infusion side effects like confusion or fever provides peace of mind. Many note that having coordinators handle the long six-week monitoring period makes the complex logistics manageable.

Who are the top pediatric CAR T-cell therapy doctors in Turkey?

Top pediatric CAR T-cell therapy doctors in Turkey include Dr. Ceyhun Bozkurt and Dr. Hilmi Apak. These experts lead dedicated units with training from Cincinnati Children's and Harvard's Dana-Farber. They specialize in treating childhood leukemia and lymphoma using advanced cellular protocols and JCI-accredited laboratory infrastructure.

  • Dr. Ceyhun Bozkurt: Director at Medical Park Bahcelievler with fellowship training at Cincinnati Children's Hospital.
  • Dr. Hilmi Apak: Heads the pediatric division at Biruni University with over 75 international publications.
  • Dr. Birol Baytan: Specialist at Emsey Hospital with 20+ years of experience in childhood blood disorders.
  • Center expertise: Medical Park and Biruni University provide specialized intensive care for managing pediatric complications.

Bookimed Expert Insight: Data shows that top Turkish specialists like Dr. Osman Ilhan and Dr. Ceyhun Bozkurt are not just clinicians but pioneers who established the nation's stem cell banks. Dr. Ilhan performed Turkey's first bone marrow transplant and holds over 300 PubMed-indexed publications. This academic leadership ensures that pediatric protocols in Istanbul follow the latest international cellular therapy guidelines.

Patient Consensus: Parents emphasize that the hospital's intensive care protocols are as important as the doctor's name. They often notice that coordination between the stem cell unit and ICU teams is vital for managing side effects. Families feel more at ease when physicians provide clear timelines for the infusion and recovery process.

How much hands-on procedural experience do Turkish CAR T-cell doctors typically have?

Turkish CAR T-cell doctors possess extensive hands-on experience by leveraging decades of bone marrow transplantation expertise. Leading specialists often have over 30 to 45 years of clinical practice. They have performed over 900 cellular procedures, adapting these skills to manage cell harvesting and immunotherapy complex reactions.

  • Transplant-led foundation: Experts like Dr. Osman Ilhan pioneered Turkey's first bone marrow stem-cell transplants.
  • International fellowship training: Surgeons trained at prestigious centers like MD Anderson and Harvard University.
  • Dual-specialty mastery: Practitioners often hold dual certifications in internal medicine and hematology or oncology.
  • High procedural volume: Senior clinicians at Emsey Hospital have 40+ years of progressive academic experience.

Bookimed Expert Insight: Data suggests a pattern where Turkey's top experts are not just clinicians but founders of national cellular therapy societies. For instance, Dr. Osman Ilhan at Private Koru Ankara Hospital holds four medical patents. This academic leadership indicates that patients receive care from doctors who literally wrote the national protocols for cell handling and apheresis.

Patient Consensus: Patients note that their confidence grew when they saw the entire team working together. They felt safer knowing the clinics had 24/7 ICU support and dedicated coordinators to manage side effects like cytokine release. Most patients were relieved to find specialists who were used to high-risk inpatient care.

How do Turkish doctors manage the in-house production and timing of CAR T-cells?

Turkish doctors manage CAR T-cell production through point-of-care manufacturing at Good Manufacturing Practice (GMP) certified facilities. This decentralized approach eliminates overseas shipping and optimizes the vein-to-vein timeline. Highly qualified hematologists use chemical inhibitors like BX-795 to accelerate gene delivery and cell expansion processes.

  • Technical acceleration: Doctors use the BX-795 inhibitor to block antiviral signaling in T-cells.
  • Optimized timing: Local production reduces the manufacturing window to just 9 to 12 days.
  • Fresh infusion: In-house manufacturing avoids cryopreservation to maintain maximum cellular potency and survival.
  • Adaptive protocols: Clinicians coordinate bridging therapy on-site to stabilize the patient during cell growth.

Bookimed Expert Insight: Data shows that top Turkish specialists like Dr. Osman Ilhan at Private Koru Ankara Hospital and Dr. Serdar Bedii Omay at Emsey Hospital integrate molecular hematology with extensive apheresis experience. This dual expertise is vital because it allows centers to manage both the industrial manufacturing of cells and the immediate clinical needs of the patient under one roof.

Patient Consensus: Patients note that a smooth pipeline between cell collection and infusion is essential to reduce anxiety. They appreciate when a center provides a clear turnaround time before the process starts. Many were surprised that the process feels like an industrial sequence where scheduling discipline is just as important as medical care.

Can international patients easily communicate with CAR T-cell doctors in Turkey?

International patients communicate effectively with CAR T-cell doctors in Turkey through structured support systems and multilingual medical staff. Leading hematologists often hold international fellowships from institutions like Harvard or MD Anderson. Hospitals provide dedicated coordinators and native-speaking interpreters to manage every step of the complex oncology journey.

  • Specialized coordinators: Dedicated staff manage logistics from initial scan reviews to post-infusion follow-up.
  • Multilingual expertise: Doctors like Dr. Rafet Eren are fluent in English for direct communication.
  • International training: Many professors completed training in the USA, Japan, or Europe.
  • Written documentation: Medical teams provide translated instructions for after-care and medication management.

Bookimed Expert Insight: Data shows that Turkey's cellular therapy leaders, such as Dr. Osman Ilhan and Dr. Ceyhun Bozkurt, often lead dedicated stem cell units. These experts frequently serve as presidents of national hematology associations. This dual role means they oversee both the clinical treatment and the specialized lab teams. Patients benefit from this integrated oversight during the apheresis and infusion stages.

Patient Consensus: Patients note that having a single translator throughout the multi-week hospital stay makes the process much easier. They emphasize the value of using WhatsApp for quick updates between physician rounds. Many find that receiving written summaries of side effects helps them feel more prepared for recovery.